Severity of Guillain-Barré syndrome is associated with Fcγ Receptor III polymorphisms

Journal of Neuroimmunology

Volumn 162, Issue 1-2, 2005, Pages 157-164

  Van Sorge, Nina M ^a   Van Der Pol, W Ludo ^a   Jansen, Marc D ^a   Geleijns, Karin P W ^b   Kalmijn, Sandra ^a   Hughes, Richard A C ^d   Rees, Jeremy H ^f   Pritchard, Jane ^d   Vedeler, Christian A ^e   Myhr, Kjell Morten ^e   Shaw, Chris ^d   Van Schaik, Ivo N ^c   Wokke, John H J ^a   Van Doorn, Pieter A ^b   Jacobs, Bart C ^b   Van De Winkel, Jan G J ^a,g   Van Den Berg, Leonard H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d GUY S HOSPITAL   (United Kingdom)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^g GENMAB   (Netherlands)

Author keywords

Fc R; Guillain Barr syndrome; Polymorphism

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; GUILLAIN BARRE SYNDROME; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 20144388163     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.01.016     Document Type: Article

References (39)

1. A.K. Asbury, and D.R. Cornblath Assessment of current diagnostic criteria for Guillain-Barré syndrome Ann. Neurol. 27 1990 S21 S24
2. M. Botto, E. Theodoridis, E.M. Thompson, H.L. Beynon, D. Briggs, D.A. Isenberg, M.J. Walport, and K.A. Davies Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease Clin. Exp. Immunol. 104 1996 264 268
3. G. Cartron, L. Dacheux, G. Salles, P. Solal-Celigny, P. Bardos, P. Colombat, and H. Watier Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene Blood 99 2002 754 758
4. M.C. Dalakas Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies Neurology 59 2002 S13 S21
5. R.S. Davis, Y.H. Wang, H. Kubagawa, and M.D. Cooper Identification of a family of Fc receptor homologs with preferential B cell expression Proc. Natl. Acad. Sci. U. S. A. 98 2001 9772 9777
6. M. de Haas, M. Kleijer, R. van Zwieten, D. Roos, and A.E. von dem Borne Neutrophil Fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families Blood 86 1995 2403 2413
7. J.C. Edberg, C.D. Langefeld, J. Wu, K.L. Moser, K.M. Kaufman, J. Kelly, V. Bansal, W.M. Brown, J.E. Salmon, S.S. Rich, J.B. Harley, and R.P. Kimberly Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus Arthritis Rheum. 46 2002 2132 2140
8. C.A. Fijen, R.G. Bredius, E.J. Kuijper, T.A. Out, M. De Haas, A.P. De Wit, M.R. Daha, and J.G. De Winkel The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals Clin. Exp. Immunol. 120 2000 338 345
9. T. Fujioka, E. Purev, S.G. Kremlev, E.S. Ventura, and A. Rostami Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis J. Neuroimmunol. 108 2000 181 191
10. G. Gambaro, F. Anglani, and A. D'Angelo Association studies of genetic polymorphisms and complex disease Lancet 355 2000 308 311
11. J.W. Griffin, G. Stoll, C.Y. Li, W. Tyor, and D.R. Cornblath Macrophage responses in inflammatory demyelinating neuropathies Ann. Neurol. 27 1990 S64 S68
12. R.D. Hadden, D.R. Cornblath, R.A. Hughes, J. Zielasek, H.P. Hartung, K.V. Toyka, and A.V. Swan Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group Ann. Neurol. 44 1998 780 788
13. R.D. Hadden, H. Karch, H.P. Hartung, J. Zielasek, B. Weissbrich, J. Schubert, A. Weishaupt, D.R. Cornblath, A.V. Swan, R.A. Hughes, and K.V. Toyka Preceding infections, immune factors, and outcome in Guillain-Barré syndrome Neurology 56 2001 758 765
14. H.P. Hartung, and K.V. Toyka T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome Ann. Neurol. 27 1990 S57 S63
15. Y. Hatta, N. Tsuchiya, J. Ohashi, M. Matsushita, K. Fujiwara, K. Hagiwara, T. Juji, and K. Tokunaga Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese Genes Immun. 1 1999 53 60
16. R.A. Hughes, and J.H. Rees Clinical and epidemiologic features of Guillain-Barré syndrome J. Infect. Dis. 176 1997 S92 S98
17. B.C. Jacobs, P.A. van Doorn, P.I. Schmitz, A.P. Tio-Gillen, P. Herbrink, L.H. Visser, H. Hooijkass, and F.G. van der Meche Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome Ann. Neurol. 40 1996 181 187
18. B.C. Jacobs, P.H. Rothbarth, F.G. van der Meche, P. Herbrink, P.I. Schmitz, M.A. de Klerk, and P.A. van Doorn The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study Neurology 51 1998 1110 1115
19. R.P. Kimberly, J.C. Edberg, L.T. Merriam, S.B. Clarkson, J.C. Unkeless, and R.P. Taylor In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees J. Clin. Invest. 84 1989 962 970
20. T. Kobayashi, N. Sugita, W.L. van der Pol, Y. Nunokawa, N.A. Westerdaal, K. Yamamoto, J.G.J van de Winkel, and H. Yoshie The Fcgamma receptor genotype as a risk factor for generalized early-onset periodontitis in Japanese patients J. Periodontol. 71 2000 1425 1432
21. T. Lehrnbecher, C.B. Foster, S. Zhu, S.F. Leitman, L.R. Goldin, K. Huppi, and S.J. Chanock Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations Blood 94 1999 4220 4232
22. F.G. Leppers-van de Straat, W.L. van der Pol, M.D. Jansen, N. Sugita, H. Yoshie, T. Kobayashi, and J.G.J. van de Winkel A novel PCR-based method for direct Fc gamma receptor IIIa (CD16) allotyping J. Immunol. Methods 242 2000 127 132
23. M. Ogino, N. Orazio, and N. Latov IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses J. Neuroimmunol. 58 1995 77 80
24. J.H. Rees, S.E. Soudain, N.A. Gregson, and R.A. Hughes Campylobacter jejuni infection and Guillain-Barré syndrome N. Engl. J. Med. 333 1995 1374 1379
25. J.E. Salmon, S.S. Millard, N.L. Brogle, and R.P. Kimberly Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner J. Clin. Invest. 95 1995 2877 2885
26. L.J. Smyth, N. Snowden, D. Carthy, C. Papasteriades, A. Hajeer, and W.E. Ollier Fc gamma RIIa polymorphism in systemic lupus erythematosus Ann. Rheum. Dis. 56 1997 744 746
27. F.G. van der Meche, and P.I. Schmitz A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group N. Engl. J. Med. 326 1992 1123 1129
28. W.L van der Pol, and J.G.J. van de Winkel IgG receptor polymorphisms: risk factors for disease Immunogenetics 48 1998 222 232
29. W.L. van der Pol, L.H. van den Berg, R.H. Scheepers, J.G. van der Bom, P.A. van Doorn, R. van Koningsveld, M.C. van den Broek, J.H. Wokke, and J.G.J. van de Winkel IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barré syndrome Neurology 54 2000 1661 1665
30. W.L. van der Pol, M.D. Jansen, W.J. Sluiter, B. van de Sluis, F.G. Leppers-van de Straat, T. Kobayashi, R.G. Westendorp, T.W. Huizinga, and J.G.J. van de Winkel Evidence for non-random distribution of Fcgamma receptor genotype combinations Immunogenetics 55 2003 240 246
31. N.M. Van Sorge, L.H. Van Den Berg, K. Geleijns, J.A. Van Strijp, B.C. Jacobs, P.A. Van Doorn, J.H. Wokke, J.G.J Van De Winkel, J.H. Leusen, and W.L. Van Der Pol Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors Ann. Neurol. 53 2003 570 579
32. N.M. Van Sorge, W.L. Van Der Pol, and J.G.J. Van De Winkel FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy Tissue Antigens 61 2003 189 202
33. N.M. van Sorge, W.L. van der Pol, M.D. Jansen, and L.H. van den Berg Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome Autoimmun. Rev. 3 2004 61 68
34. C.A. Vedeler, G. Raknes, K.M. Myhr, and H. Nyland IgG Fc-receptor polymorphisms in Guillain-Barré syndrome Neurology 55 2000 705 707
35. C.A. Vedeler, K. Myhr, and H. Nyland Fc receptors for immunoglobulin G-a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis J. Neuroimmunol. 118 2001 187 193
36. M.T. Walsh, A. Divane, and A.S. Whitehead Fine mapping of the human pentraxin gene region on chromosome 1q23 Immunogenetics 44 1996 62 69
37. P.A. Warmerdam, J.G.J van de Winkel, A. Vlug, N.A. Westerdaal, and P.J. Capel A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding J. Immunol. 147 1991 1338 1343
38. H.J. Willison, and N. Yuki Peripheral neuropathies and anti-glycolipid antibodies Brain 125 2002 2591 2625
39. J. Wu, J.C. Edberg, P.B. Redecha, V. Bansal, P.M. Guyre, K. Coleman, J.E. Salmon, and R.P. Kimberly A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease J. Clin. Invest. 100 1997 1059 1070